CLINICAL_TRIALS
trial_result
· 2022-11-02
Clinical Trial Update: Citocoline for Treatment in Fragile X-associated Tremor/Ataxia Syndrome [Phase 2]
Summary
Phase 2 trial of citocoline for Fragile X-associated Tremor/Ataxia Syndrome has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rush University Medical Center | Conditions: Fragile X Tremor/Ataxia Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2022-11-02